Company Filing History:
1 out of 915 
1 out of 2,341 
Years Active: 2025
Title: Yanran He: Innovator in Cancer Treatment
Introduction
Yanran He is a prominent inventor based in Chicago, IL, who has made significant contributions to the field of cancer treatment. His innovative work focuses on developing therapies that utilize chimeric antigen receptors to target specific cancer cells. With a strong academic background and a commitment to advancing medical science, He has become a notable figure in the realm of immunotherapy.
Latest Patents
Yanran He holds a patent for a groundbreaking cancer treatment titled "Cancer treatment with 237 CAR-T cell based therapeutics recognizing the Tn epitope." This patent encompasses Tn epitope-specific chimeric antigen receptors and single-chain variable fragments (scFvs), including both soluble and multimeric forms. The disclosure also outlines methods for identifying cancer subjects and sub-populations that are amenable to anti-Tn immunotherapy, as well as techniques for treating cancer effectively.
Career Highlights
Throughout his career, Yanran He has worked with esteemed institutions such as the University of Chicago and the University of Illinois. His research has focused on the intersection of immunology and oncology, leading to advancements in targeted cancer therapies. His dedication to improving patient outcomes through innovative treatments has garnered attention in the scientific community.
Collaborations
Yanran He has collaborated with notable colleagues, including Hans Schreiber and David M Kranz. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his research in cancer treatment.
Conclusion
In summary, Yanran He is a distinguished inventor whose work in cancer treatment is paving the way for new therapeutic approaches. His patent on CAR-T cell based therapeutics represents a significant advancement in the fight against cancer. Through his collaborations and research, He continues to contribute to the field of immunotherapy, making a lasting impact on medical science.